关键数据
3.320今开
3.410最高
648.54K成交量
14.56市盈率 TTM
12.06市盈率动
--股息TTM
0.82%换手率
3.320昨收
3.210最低
1.48M成交额
31.60市盈率静
3.28市净率
0.00%股息率 TTM
19.05%ROA
14.69052周最高
1.09量比
8.55M净利润
79.46M总股本
0.2335每股收益TTM
2.19Beta
27.07%ROE
4.16052周最低
6.02%振幅
63.47%毛利率
270.79M总市值
-1.71回报/风险
3.01%风险率
操作建议
Niagen Bioscience Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名78/385位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价12.42。中期看,股价处于下降通道。近一个月,市场表现一般,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
Niagen Bioscience Inc评分
压力支撑

由于公司未披露,未能获取相关数据
Niagen Bioscience Inc亮点
亮点风险
Niagen Bioscience Inc新闻
即将为您带来更多新闻,敬请期待。。。
收益预测
Niagen Bioscience Inc
NAGE
6
Ionis Pharmaceuticals Inc
IONS
27
Kymera Therapeutics Inc
KYMR
24
技术指标
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
Niagen Bioscience Inc简介
Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
公司代码NAGE
公司Niagen Bioscience Inc
CEOFried (Robert N)
网址https://www.niagenbioscience.com/
公司股东
常见问题
Niagen Bioscience Inc(NAGE)的当前股价是多少?
Niagen Bioscience Inc(NAGE)的当前股价是 3.40。
Niagen Bioscience Inc的股票代码是什么?
Niagen Bioscience Inc的股票代码是NAGE。
Niagen Bioscience Inc股票的52周最高点是多少?
Niagen Bioscience Inc股票的52周最高点是14.69。
Niagen Bioscience Inc股票的52周最低点是多少?
Niagen Bioscience Inc股票的52周最低点是4.16。
Niagen Bioscience Inc的市值是多少?
Niagen Bioscience Inc的市值是270.15M。
现在Niagen Bioscience Inc(NAGE)的股票是买入、持有还是卖出?
根据分析师评级,Niagen Bioscience Inc(NAGE)的总体评级为买入,目标价格为12.42。
Niagen Bioscience Inc(NAGE)股票的每股收益(EPS TTM)是多少
Niagen Bioscience Inc(NAGE)股票的每股收益(EPS TTM)是0.22。